P S Bunting

Summary

Publications

  1. doi request reprint Do guidelines for the diagnosis and monitoring of diabetes mellitus fulfill the criteria of evidence-based guideline development?
    Eva Nagy
    Department of Clinical Chemistry, University of Szeged, Medical Faculty, Szeged, Hungary
    Clin Chem 54:1872-82. 2008
  2. ncbi request reprint Screening for prostate cancer with prostate-specific antigen: beware the biases
    Peter S Bunting
    Gamma Dynacare Medical Laboratories, 115 Midair Court, Brampton, Ontario, Canada L6T 5M3
    Clin Chim Acta 315:71-97. 2002
  3. ncbi request reprint Screening with prostate specific antigen and metastatic prostate cancer risk: a population based case-control study
    Jacek A Kopec
    Department of Health Care and Epidemiology, University of British Columbia, Vancouver, Canada
    J Urol 174:495-9; discussion 499. 2005
  4. ncbi request reprint A reliable coding system to define screening prostate-specific antigen tests was developed in a case-control study
    Peter S Bunting
    Division of Biochemistry, Department of Pathology and Laboratory Medicine, University of Ottawa, Ontario, Canada
    J Clin Epidemiol 58:639-44. 2005
  5. ncbi request reprint Has there been a change in practice of screening for prostate cancer with prostate-specific antigen in Ontario?
    Peter S Bunting
    Department of Pathology and Laboratory Medicine, The Ottawa Hospital, University of Ottawa, Ottawa, ON, K1Y 4E9, Canada
    Clin Biochem 37:898-903. 2004
  6. ncbi request reprint Laboratory survey of prostate-specific antigen testing in Ontario updated
    Peter S Bunting
    Department of Pathology and Laboratory Medicine, The Ottawa Hospital, Ottawa, ON, Canada
    Clin Biochem 37:418-21. 2004
  7. ncbi request reprint Intraindividual variation of PSA, free PSA and complexed PSA in a cohort of patients with prostate cancer managed with watchful observation
    Peter S Bunting
    Department of Clinical Pathology, Sunnybrook and Women s College Health Sciences Centre, Toronto, Ontario, Canada
    Clin Biochem 35:471-5. 2002
  8. ncbi request reprint Reliability of point-of-care testing for glucose measurement in critically ill adults
    Salmaan Kanji
    Department of Pharmacy, The Ottawa Hospital, Ottawa, Canada
    Crit Care Med 33:2778-85. 2005
  9. ncbi request reprint Conflict between guideline methodologic quality and recommendation validity: a potential problem for practitioners
    Joseph Watine
    Laboratoire de biologie polyvalente, Centre Hospitalier Général de Rodez, Rodez, France
    Clin Chem 52:65-72. 2006
  10. ncbi request reprint [Mass screening for colorectal cancer with the guaiac fecal occult blood test: possible population benefits, proven individual risks]
    Joseph C Watine
    Presse Med 37:363-6. 2008

Collaborators

Detail Information

Publications11

  1. doi request reprint Do guidelines for the diagnosis and monitoring of diabetes mellitus fulfill the criteria of evidence-based guideline development?
    Eva Nagy
    Department of Clinical Chemistry, University of Szeged, Medical Faculty, Szeged, Hungary
    Clin Chem 54:1872-82. 2008
    ..Therefore, we assessed the methodological quality of GLs providing diagnostic recommendations for managing diabetes mellitus (DM) and explored several reasons for differences in quality across these GLs...
  2. ncbi request reprint Screening for prostate cancer with prostate-specific antigen: beware the biases
    Peter S Bunting
    Gamma Dynacare Medical Laboratories, 115 Midair Court, Brampton, Ontario, Canada L6T 5M3
    Clin Chim Acta 315:71-97. 2002
    ..The evidence relating to the use of prostate-specific antigen (PSA) as a screening test is a highly controversial, as demonstrated by the lack of agreement among experts. There may be biases associated with various studies...
  3. ncbi request reprint Screening with prostate specific antigen and metastatic prostate cancer risk: a population based case-control study
    Jacek A Kopec
    Department of Health Care and Epidemiology, University of British Columbia, Vancouver, Canada
    J Urol 174:495-9; discussion 499. 2005
    ..There is limited evidence that screening is effective in reducing mortality from prostate cancer. In the current study we determined if screening with PSA reduces the risk of metastatic prostate cancer...
  4. ncbi request reprint A reliable coding system to define screening prostate-specific antigen tests was developed in a case-control study
    Peter S Bunting
    Division of Biochemistry, Department of Pathology and Laboratory Medicine, University of Ottawa, Ontario, Canada
    J Clin Epidemiol 58:639-44. 2005
    ..To establish the reliability of a coding system for screening and diagnostic prostate-specific antigen (PSA) testing from patient charts...
  5. ncbi request reprint Has there been a change in practice of screening for prostate cancer with prostate-specific antigen in Ontario?
    Peter S Bunting
    Department of Pathology and Laboratory Medicine, The Ottawa Hospital, University of Ottawa, Ottawa, ON, K1Y 4E9, Canada
    Clin Biochem 37:898-903. 2004
    ..To determine whether there has been a change in the rate of screening in Ontario in 2002 compared to 1995...
  6. ncbi request reprint Laboratory survey of prostate-specific antigen testing in Ontario updated
    Peter S Bunting
    Department of Pathology and Laboratory Medicine, The Ottawa Hospital, Ottawa, ON, Canada
    Clin Biochem 37:418-21. 2004
  7. ncbi request reprint Intraindividual variation of PSA, free PSA and complexed PSA in a cohort of patients with prostate cancer managed with watchful observation
    Peter S Bunting
    Department of Clinical Pathology, Sunnybrook and Women s College Health Sciences Centre, Toronto, Ontario, Canada
    Clin Biochem 35:471-5. 2002
    ..To determine the intraindividual variation of prostate-specific antigen (PSA) isoforms in prostate cancer patients managed conservatively with watchful observation...
  8. ncbi request reprint Reliability of point-of-care testing for glucose measurement in critically ill adults
    Salmaan Kanji
    Department of Pharmacy, The Ottawa Hospital, Ottawa, Canada
    Crit Care Med 33:2778-85. 2005
    ..Therefore, it is imperative that bedside glucose testing methods be safe and accurate...
  9. ncbi request reprint Conflict between guideline methodologic quality and recommendation validity: a potential problem for practitioners
    Joseph Watine
    Laboratoire de biologie polyvalente, Centre Hospitalier Général de Rodez, Rodez, France
    Clin Chem 52:65-72. 2006
    ....
  10. ncbi request reprint [Mass screening for colorectal cancer with the guaiac fecal occult blood test: possible population benefits, proven individual risks]
    Joseph C Watine
    Presse Med 37:363-6. 2008
  11. doi request reprint Mass colorectal cancer screening: methodological quality of practice guidelines is not related to their content validity
    Joseph C Watine
    Laboratoire de biologie polyvalente, Centre Hospitalier General, Rodez, France
    Clin Biochem 41:459-66. 2008
    ..We assessed whether or not there is a link between methodological quality and recommendation validity in GLs for the use of fecal occult blood test (FOBT) as a screening test for colorectal cancer (CRC) in the average-risk population...